MD SB497 | 2024 | Regular Session
Status
Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 24 2024 - 25% progression, died in chamber
Action: 2024-03-04 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 24 2024 - 25% progression, died in chamber
Action: 2024-03-04 - Withdrawn by Sponsor
Text: Latest bill text (Introduced) [PDF]
Summary
Requiring the Maryland Medical Assistance Program and certain insurers, nonprofit health service plans, and health maintenance organizations to cover nonprescription naloxone hydrochloride and any other drug or product that is approved by the federal Food and Drug Administration for the complete or partial reversal of an opioid overdose without imposing a copayment or coinsurance requirement that exceeds $10 per package.
Title
Health Insurance and Maryland Medical Assistance Program - Coverage - Opioid Reversal Drugs and Products
Sponsors
Sen. Dawn Gile [D] |
History
Date | Chamber | Action |
---|---|---|
2024-03-04 | Senate | Withdrawn by Sponsor |
2024-02-05 | Senate | Hearing canceled |
2024-01-24 | Senate | Hearing 2/07 at 2:00 p.m. |
2024-01-24 | Senate | First Reading Finance |
Same As/Similar To
HB736 (Crossfiled) 2024-02-26 - Withdrawn by Sponsor
Subjects
Controlled Dangerous Substances
Drugs
Federal Government
Health
Health - Insurance
Health Insurance
Health Maintenance Organizations
Managed Care Organizations
Medical Assistance
Nonprofit Organizations
Opioids
Pharmacy Benefits Managers
Prices
Public Health
Substance Abuse Treatment
Drugs
Federal Government
Health
Health - Insurance
Health Insurance
Health Maintenance Organizations
Managed Care Organizations
Medical Assistance
Nonprofit Organizations
Opioids
Pharmacy Benefits Managers
Prices
Public Health
Substance Abuse Treatment
Code Citations
Chapter | Article | Section | Citation Type | Statute Text |
---|---|---|---|---|
Health - General | 15 | 102.3 | (n/a) | See Bill Text |
Health - General | 15 | 103 | (n/a) | See Bill Text |
Insurance | 15 | 850.1 | (n/a) | See Bill Text |